Three datasets were identified and gene expression data were analyzed for each of the known targets in AML-derived samples (total from all 3 datasets, n = 69) and healthy donor CD34-selected cells (total from all 3 datasets, n = 40). Here, CD34 is linked to acute myeloid leukemia.